Citations

Clear

6873 citation(s) found for "Paul, A".

Developing and prioritizing standardized quality measures for pharmacist-led care of inflammatory bowel disease with a modified Delphi process
Becker, Michelle D, Groehler, Paul N., Buechel, Bryan J, Haag, Jordan D

Mayo Clinic

American Journal of Health-System Pharmacy | November 20, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1093/ajhp/zxag409 | PMID 43066513 Get It

Abstract Purpose Pharmacist management of care for patients with inflammatory bowel disease (IBD) encompasses therapy education and optimization, monitoring, adherence support, and immunosuppression safety processes and thereby holds substantial promise for improving patient outcomes. However, the absence of a structured set of quality measures often results in fragmented efforts among clinic-based pharmacists, specialty pharmacy pharmacists, and managed care pharmacists. To address this shortcoming, we used an established modified Delphi process to develop and prioritize pharmacist-driven quality measures for the care of patients with IBD. Methods This multisite project was conducted at Mayo Clinic in Minnesota, Arizona, and Florida from October 30, 2023, through February 6, 2024. Stakeholders included IBD physicians, clinic-based pharmacists in medication management services, specialty pharmacy pharmacists, managed care pharmacists, and pharmacy leadership. An environmental scan identified existing quality measures, and a subsequent 3-round modified Delphi process was used to rate the quality measures for importance, feasibility, and validity before final ranking and consensus review. Results Thirty-one potential quality measures were identified. We prioritized 10 quality measures that emphasized adherence, safety screening, and timeliness of treatment initiation. These consensus-derived quality measures provided a foundation for systemwide performance tracking and quality improvement in pharmacist-led IBD care. Conclusion Prioritized quality measures were successfully identified to create a consistent, systemwide quality framework for pharmacist-led IBD care. Implementation of shared documentation standards and electronic health record–embedded tools are critical next steps to streamline efforts and monitor their effects on the quality of care for patients with IBD.
Brachytherapy Returns to the Brain: The ROADS Trial and a Second Look at Cavity Radiosurgery
Lehrer, Eric J , Brown, Paul D

Mayo Clinic

Journal of Clinical Oncology | November 16, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1200/jco-26-02475 | PMID 43038496 Get It

Flexibility in Device Sizing with a Next-Generation LAA Occluder in the VERITAS Study
Makkar, Akash , Nair, Devi G , Agarwal, Himanshu , Abuissa, Hussam, Awad, Khaled , Backer, Ole De , Lakkireddy, Dhanunjaya, Ellis, Christopher R. , Shah, Dipak, Alkhouli, Mohamad, Nielsen‐Kudsk, Jens Erik , Weiler, Courtney , Freixa, Xavier

Mayo Clinic

Europace | November 14, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1093/europace/euag323 | PMID 43036870 Get It

Real-World Experience of Concomitant Isavuconazole and Vincristine Administration
Shieb, Mohamad , Madigan, Theresa , Gaensbauer, James , Blunier, Abbie L , Guggenburger, John, Galardy, Paul, O'Keefe, Madeleine

Mayo Clinic

Journal of the Pediatric Infectious Diseases Society | November 10, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1093/jpids/piag116 | PMID 43007301 Get It

Three pediatric oncology patients received isavuconazole concurrently with vincristine across 15 days to approximately 23 months, spanning 32 vincristine doses. No severe adverse effect including neurotoxicity or paralytic ileus was attributed to the combination.
Drawing the Sacred: Visualizing Where Hope Lives in Hispanic Adolescent and Young Adult Cancer Survivorship
Bennett, Claire , Galchutt, Paul , Hendricks‐Ferguson, Verna L.

Mayo Clinic

Journal of Adolescent and Young Adult Oncology | November 6, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1177/21565333261504199 | PMID 42993590 Get It

Purpose: Spirituality can shape coping and meaning-making for adolescents and young adults (AYAs) with cancer, but its expression is culturally situated and may not be fully captured through interviews alone. This study examined how Hispanic AYA cancer survivors represented spirituality and hope through participant-generated drawings. Methods: This descriptive, arts-based qualitative inquiry was nested within a phenomenology-informed parent study. Ten Hispanic AYA cancer survivors completed semistructured interviews with a prospectively embedded electronic drawing activity. A board-certified art therapist conducted inductive visual thematic analysis of drawings alongside participants’ explanations; candidate themes were reviewed through team discussion and compared with previously published narrative themes. Results: Participants were 22–36 years old; seven were female and three were male, eight participants preferred to use the Spanish language, and two preferred to use the English language. Visual themes were Reliable Companionship, Religious Beliefs, and Safe Place and Containment. Participant-generated titles, explicit words and symbols, and verbal explanations anchored their interpretation. The visual dataset emphasized supportive spirituality and hope, although negative or ambiguous illness imagery also appeared. Conclusion: Participant-generated drawings offered an additional, participant-led way to examine spirituality, relationships, and place in this Hispanic AYA survivor sample. Visual methods may complement interviews when interpretation remains grounded in participants’ own meanings and culturally sensitive questioning.
Agentic AI-Generated vs. Clinician-Authored Hospital Course Narratives for Cardiology Hospitalizations: A Blinded Physician Evaluation
Lee, Eunjung , Harmon, David , Holmes, Jason , Allman, Alexandra E. , Saey, Stephanie , Schlesinger, Reid P , Félix, Iuri Ferreira , Friedman, Paul A , Attia, Zachi I.

Mayo Clinic

Circulation: Population Health and Outcomes | November 6, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1161/circoutcomes.126.014472 | PMID 42993583 Get It

Background: Discharge summaries are essential for safe transitions of care, but writing the hospital course narrative is time intensive. Large language models can generate plausible clinical narratives, yet prior approaches often rely on static inputs and remain vulnerable to omissions and factual inconsistencies. Methods: We developed an electronic health record (EHR)-integrated agentic artificial intelligence (AI) system that uses Gemini 2.5 Pro and Model Context Protocol tools to retrieve clinical notes, diagnostic reports, diagnoses, medications, and appointments on demand. In this retrospective, blinded, paired study, 50 inpatient cardiology encounters were randomly selected from admissions July 13 to 27, 2024, at Mayo Clinic, Rochester, Minnesota. Five physicians rated AI-generated and clinician-authored hospital course narratives for each encounter (250 ratings) on 0-to-10 scales for overall quality, clarity, completeness, accuracy, and readability and indicated a preference. The primary outcome was the paired difference in overall quality (linear mixed-effects model with crossed random intercepts for encounter and reviewer). Secondary domains were analyzed similarly with Bonferroni adjustment, and preference with a crossed random-effects logistic model. Results: Clinician-authored narratives were preferred in 132 ratings (52.8%) and AI-generated narratives in 118 (47.2%) (odds ratio for clinician-authored preference, 1.12; 95% CI, 0.71 to 1.78). Overall quality did not differ significantly (mean, 7.27 AI-generated versus 7.42 clinician-authored; difference, -0.15; 95% CI, -0.86 to 0.56; p=0.627). AI-generated narratives were rated higher for clarity (0.36; 95% CI, 0.07 to 0.65) and readability (0.72; 95% CI, 0.20 to 1.24) but lower for completeness (-0.84; 95% CI, -1.36 to -0.32) and accuracy (-0.35; 95% CI, -0.66 to -0.05). After Bonferroni correction, only lower completeness remained significant (adjusted p=0.012). Conclusions: Hospital course narratives generated by the EHR-integrated agentic AI system did not differ significantly from clinician-authored narratives in physician-rated overall quality or preference. Lower completeness supports continued clinician review before use in the medical record.
Penicillin Allergy Delabeling in Children
Larson, Anthony S. , Lim, Peter Paul , Angal, Jyoti , Perry, Tamara T. , Blumenthal, Kimberly G.

Mayo Clinic

Pediatrics | November 4, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1542/peds.2026-077964 | PMID 42976931 Get It

Nearly 10% of the global population has been labeled as having a penicillin allergy. Of those labeled, about 95% are not truly allergic, yet most do not receive any allergy evaluations. Patients with penicillin allergy labels are more likely to have worse clinical outcomes and incur higher health care costs, largely because they do not receive penicillin and other first-line β-lactam antibiotics for the treatment of infectious diseases. Consequently, the process of evaluating and removing inaccurate penicillin allergy labels—a process known as “delabeling”—has become increasingly supported by a growing body of evidence. Recently, penicillin allergy has garnered substantial public interest with the proposal of federal legislation to include evaluation of penicillin allergy during routine medical visits for Medicare patients. Although this moves delabeling into the generalist purview, most of the emphasis on penicillin allergies and delabeling has been on adult patients. Yet, penicillin allergy is a pressing issue for pediatrics, as most penicillin allergy labels are placed in childhood. Pediatric literature similarly demonstrates negative clinical and public health consequences of inaccurate penicillin allergy labels. Recent guidelines have strongly recommended a proactive effort to identify and delabel inaccurate penicillin allergies in children. To facilitate this process, simple delabeling procedures, such as direct oral challenge with amoxicillin, have been recommended for patients with low-risk allergy status, based on historical reaction verification, because of their safety and accuracy. These advancements are relevant to practicing pediatricians across specialties and practice locations.
Cost-Effectiveness of Anterior and Posterior Surgical Approaches for Cervical Spondylotic Myelopathy: An Economic Evaluation of a Randomized Clinical Trial
Whitmore, Robert G. , Miranda, Stephen P. , Bydon, Mohamad , Dholakia, Ruchita, Moriarty, James P. , Borah, Bijan J. , Kanter, Adam S., Mummaneni, Praveen V. , Bisson, Erica F. , Harrop, James S., Magge, Subu N., Heary, Robert F., Fehlings, Michael G. , Albert, Todd J. , Arnold, Paul M., Riew, Kiehyun Daniel , Steinmetz, Michael P., Benzel, Edward, Wang, Marjorie C., Heller, John G., Ghogawala, Zoher

Mayo Clinic

Neurosurgery | November 3, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1227/neu.0000000000004268 | PMID 42975416 Get It

BACKGROUND AND OBJECTIVES: Surgery for cervical spondylotic myelopathy improves quality of life but remains expensive. We conducted a cost-effectiveness analysis of patients treated with anterior cervical diskectomy/fusion (ACDF), posterior cervical decompression/fusion (PCDF), and laminoplasty (LP) in the Cervical Spondylotic Myelopathy Surgical (CSM-S) Trial, a randomized trial comparing surgical approaches for cervical spondylotic myelopathy. METHODS: In the trial, patients were randomized (2:3) to anterior (ACDF) or posterior surgery (LP or PCDF, at surgeon's discretion). A cost-effectiveness analysis was performed from a societal perspective with a 1-year time horizon, including only US patients as-treated. Cumulative costs were estimated using patient data on utilization and lost productivity using a human capital approach. Direct costs were calculated using 2022 Medicare rates for professional fees and cost-to-charge ratios for hospital services. Quality-adjusted life-years (QALYs) were calculated from patient responses to the EuroQol-5-Dimensions instrument at baseline and 3, 6, and 12 months postoperatively. Incremental cost-effectiveness ratio analysis was performed with bootstrapping to address uncertainty. RESULTS: Of 163 total patients enrolled in the CSM-S Trial, 153 from the United States (mean age, 62 years; 80 (52%) female) were included as-treated (ACDF = 61, PCDF = 64, LP = 28) in a cost-effectiveness analysis. Economic data were not available for 9 patients. The remaining 144 patients treated (ACDF = 55, PCDF = 61, LP = 28) had cost data through a 1-year follow-up. Mean hospitalization costs were higher after PCDF than ACDF and LP ($33 410 vs $26 468 vs $25 550; P < .001). Mean total costs were higher after PCDF than ACDF and LP ($62 383 vs $53 074 vs $47 426; P = .017). LP yielded greater QALY gains than ACDF (0.792 vs 0.732; P = .08) and PCDF (0.792 vs 0.698; P = .01). At a willingness-to-pay threshold of $150 000/QALY-gained, the probability that LP was cost-effective compared with PCDF was 99.7% and the probability compared with ACDF was 96%. CONCLUSION: In the CSM-S Trial, LP yielded greater 1-year quality-of-life improvements at lower costs than PCDF and ACDF.
Comparison of oral and intravenous methadone for postoperative analgesia after cardiac surgery: a pilot randomized clinical trial
Ramanujan, Krishnan S. , Grate, Jeremy C. , Khan, Fazal , Paul, Johar , D'Souza, Ryan S

Mayo Clinic

Regional Anesthesia & Pain Medicine | October 23, 2026 | Volume: No volume available | Issue: No issue available | Pages: rapm-2026-108588

10.1136/rapm-2026-108588 | PMID 42919629 Get It

Serial Artificial Intelligence ECG-Derived Atrial Fibrillation Probability and Recurrence Risk After Pulsed Field Ablation
Sardana, Mayank , Rodriguez-Riascos, Juan F , Vemulapalli, Hema S , Kim, James , Attia, Zachi I , Wood, Julia , Mangold, Kathryn E , Friedman, Paul A , Noseworthy, Peter A , Srivathsan, Komandoor

Mayo Clinic

Circulation: Arrhythmia and Electrophysiology | October 8, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1161/circep.126.015183 | PMID 42845233 Get It

BACKGROUND: Pulsed field ablation is now widely used for atrial fibrillation (AF) ablation, but atrial tachyarrhythmia recurrence remains common and postablation risk tools are limited. We assessed whether a validated sinus‑rhythm artificial intelligence— enabled ECG AF probability score, and its early postablation change, predicts recurrence after pulsed field ablation. METHODS: We studied consecutive patients undergoing index pulsed field ablation across 3 Mayo Clinic sites (February 2024–March 2025) with ≥1 sinus‑rhythm ECG within 180 days preprocedure. Baseline artificial intelligence—enabled ECG AF score (range 0–1) was the mean across baseline ECGs. Recovery indices (RI30/60/90), defined as mean postprocedure artificial intelligence—enabled ECG score within days 1–30/60/90 minus baseline, predicted post‑blanking recurrence using corresponding 30‑, 60‑, and 90‑day blanking windows. The primary outcome was time to first documented AF/atrial flutter/atrial tachycardia episode >30 seconds, ascertained via clinic ECGs, ambulatory monitoring, and device interrogations. Cox regression adjusted for prespecified clinical and echocardiographic covariates assessed associations; Harrell C‑statistic quantified discrimination. RESULTS: Among 1052 patients (67±10 years; 33% women), median baseline score was 0.35; 320 (30%) recurred over 188 days. Higher baseline score independently predicted recurrence (hazard ratio per 0.1 increase, 1.08 [95% CI, 1.03–1.14]). Scores rose on day 0 after ablation, then declined over subsequent weeks, with persistently higher, less‑improving trajectories among patients who recurred (time×recurrence interaction P <0.001). Day 0 score was not independently associated with recurrence after adjustment. Attenuated early recovery (higher recovery index) was independently associated with recurrence, most robustly for RI-90 (hazard ratio per 0.1 increase, 1.15 [95% CI, 1.07–1.24]), and improved discrimination beyond baseline and covariates (C‑statistic, 0.63–0.67; ΔC=0.04). Findings were consistent in a historical thermal ablation cohort. CONCLUSIONS: Baseline and early postablation dynamics of a sinus‑rhythm artificial intelligence—enabled ECG AF probability score are associated with pulsed field ablation recurrence and may aid multivariable risk stratification; prospective validation is warranted.